These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Clinical features of anti-synthetase syndrome associated interstitial lung disease: a retrospective cohort in China. Zhan X; Yan W; Wang Y; Li Q; Shi X; Gao Y; Ye Q BMC Pulm Med; 2021 Feb; 21(1):57. PubMed ID: 33579248 [TBL] [Abstract][Full Text] [Related]
6. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas. Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557 [TBL] [Abstract][Full Text] [Related]
8. Aminoacyl-tRNA Synthetases: On Anti-Synthetase Syndrome and Beyond. Galindo-Feria AS; Notarnicola A; Lundberg IE; Horuluoglu B Front Immunol; 2022; 13():866087. PubMed ID: 35634293 [TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of rituximab in anti-synthetase antibody positive and negative subjects with idiopathic inflammatory myopathy: a registry-based study. Leclair V; Galindo-Feria AS; Dastmalchi M; Holmqvist M; Lundberg IE Rheumatology (Oxford); 2019 Jul; 58(7):1214-1220. PubMed ID: 30690633 [TBL] [Abstract][Full Text] [Related]
10. Regional cerebral blood flow single photon emission computed tomography for detection of Frontotemporal dementia in people with suspected dementia. Archer HA; Smailagic N; John C; Holmes RB; Takwoingi Y; Coulthard EJ; Cullum S Cochrane Database Syst Rev; 2015 Jun; 2015(6):CD010896. PubMed ID: 26102272 [TBL] [Abstract][Full Text] [Related]
11. Longitudinal assessment of reactivity and affinity profile of anti-Jo1 autoantibodies to distinct HisRS domains and a splice variant in a cohort of patients with myositis and anti-synthetase syndrome. Notarnicola A; Preger C; Lundström SL; Renard N; Wigren E; Van Gompel E; Galindo-Feria AS; Persson H; Fathi M; Grunewald J; Jakobsson PJ; Gräslund S; Lundberg IE; Fernandes-Cerqueira C Arthritis Res Ther; 2022 Mar; 24(1):62. PubMed ID: 35236390 [TBL] [Abstract][Full Text] [Related]
13. Serum Jo-1 Autoantibody and Isolated Arthritis in the Antisynthetase Syndrome: Review of the Literature and Report of the Experience of AENEAS Collaborative Group. Cavagna L; Nuño L; Scirè CA; Govoni M; Longo FJ; Franceschini F; Neri R; Castañeda S; Sifuentes Giraldo WA; Caporali R; Iannone F; Fusaro E; Paolazzi G; Pellerito R; Schwarting A; Saketkoo LA; Ortego-Centeno N; Quartuccio L; Bartoloni E; Specker C; Pina Murcia T; La Corte R; Furini F; Foschi V; Bachiller Corral J; Airò P; Cavazzana I; Martínez-Barrio J; Hinojosa M; Giannini M; Barsotti S; Menke J; Triantafyllias K; Vitetta R; Russo A; Bogliolo L; Bajocchi G; Bravi E; Barausse G; Bortolotti R; Selmi C; Parisi S; Salaffi F; Montecucco C; González-Gay MA; Clin Rev Allergy Immunol; 2017 Feb; 52(1):71-80. PubMed ID: 26782036 [TBL] [Abstract][Full Text] [Related]
14. The measurement and monitoring of surgical adverse events. Bruce J; Russell EM; Mollison J; Krukowski ZH Health Technol Assess; 2001; 5(22):1-194. PubMed ID: 11532239 [TBL] [Abstract][Full Text] [Related]
15. High prevalence of necrotising myopathy pattern in muscle biopsies of patients with anti-Jo-1 antisynthetase syndrome. da Silva LMB; Borges IBP; Shinjo SK Clin Exp Rheumatol; 2023 Mar; 41(2):238-246. PubMed ID: 36226626 [TBL] [Abstract][Full Text] [Related]
16. Clinical Spectrum Time Course in Anti Jo-1 Positive Antisynthetase Syndrome: Results From an International Retrospective Multicenter Study. Cavagna L; Nuño L; Scirè CA; Govoni M; Longo FJL; Franceschini F; Neri R; Castañeda S; Giraldo WAS; Caporali R; Iannone F; Fusaro E; Paolazzi G; Pellerito R; Schwarting A; Saketkoo LA; Ortego-Centeno N; Quartuccio L; Bartoloni E; Specker C; Murcia TP; La Corte R; Furini F; Foschi V; Corral JB; Airò P; Cavazzana I; Martínez-Barrio J; Hinojosa M; Giannini M; Barsotti S; Menke J; Triantafyllias K; Vitetta R; Russo A; Bajocchi G; Bravi E; Barausse G; Bortolotti R; Selmi C; Parisi S; Montecucco C; González-Gay MA; Medicine (Baltimore); 2015 Aug; 94(32):e1144. PubMed ID: 26266346 [TBL] [Abstract][Full Text] [Related]
17. The clinical phenotype associated with myositis-specific and associated autoantibodies: a meta-analysis revisiting the so-called antisynthetase syndrome. Lega JC; Fabien N; Reynaud Q; Durieu I; Durupt S; Dutertre M; Cordier JF; Cottin V Autoimmun Rev; 2014 Sep; 13(9):883-91. PubMed ID: 24704867 [TBL] [Abstract][Full Text] [Related]
18. Characteristics and outcomes of overlap myositis: a comparative multigroup cohort study in adults from the MyoCite cohort. Naveen R; Rathore U; Agarwal V; Gupta L Rheumatol Int; 2021 Mar; 41(3):551-563. PubMed ID: 33423071 [TBL] [Abstract][Full Text] [Related]
19. [Characteristics and clinical significance of pulmonary function test and KL-6 in ASSD-ILD and IPF]. Sun D; Cheng Z; Jiang TC; Li PF; Jia LQ; Wang TT; Zheng CP; Li Y; Duo MJ Zhonghua Yi Xue Za Zhi; 2020 Mar; 100(10):748-752. PubMed ID: 32192286 [No Abstract] [Full Text] [Related]
20. Performance of the 2017 European Alliance of Associations for Rheumatology/American College of Rheumatology Classification Criteria for Idiopathic Inflammatory Myopathies in Patients With Myositis-Specific Autoantibodies. Casal-Dominguez M; Pinal-Fernandez I; Pak K; Huang W; Selva-O'Callaghan A; Albayda J; Casciola-Rosen L; Paik JJ; Tiniakou E; Mecoli CA; Lloyd TE; Danoff SK; Christopher-Stine L; Mammen AL Arthritis Rheumatol; 2022 Mar; 74(3):508-517. PubMed ID: 34480833 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]